References

Comparison of drug approval process in United States and Europe

2013 · External reference

Contrasting clinical evidence for market authorisation of cardio-vascular devices in Europe and the USA: a systematic analysis of 10 devices based on Austrian pre-reimbursement assessments

10.1186/1471-2261-14-154 · 2014 · External reference

Regulation of medical devices in the United States and European Union

10.1056/nejmhle1113918 · 2012 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Regulation of medicines and medical devices: contrasts and similarities

10.7861/clinmedicine.14-1-6 · 2014 · External reference

Drugs, devices and the FDA: an overview of approval processes. Part 1 FDA approval processes for drugs

2016 · External reference

Drugs, devices and the FDA: an overview of approval processes. Part 2 FDA approval of medical devices

2016 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

2006 · External reference

Regulatory review of novel therapeutics—comparison of three regulatory agencies

10.1056/nejmsa1200223 · 2012 · External reference

Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in Europe

10.1377/hlthaff.2011.0231 · 2011 · External reference

Publication bias: a problem in interpreting medical data

10.2307/2982993 · 1988 · External reference

Unresolved reference

External reference

How useful are unpublished data from the Food and Drug Administration in meta-analysis?

10.1016/s0895-4356(02)00520-6 · 2003 · External reference

Opening up data at the European Medicines Agency

10.1136/bmj.d2686 · 2011 · External reference

Regulation and safe adoption of new medical devices and procedures

10.1093/bmb/ldt022 · 2013 · External reference

European medical device regulatory law and product liability

10.1016/s0195-6701(99)90083-x · 1999 · External reference

Unresolved reference

External reference

Improving medical device regulation: the United States and Europe in perspective

10.1111/1468-0009.12043 · 2014 · External reference

Registration and regulation of medical devices used in diabetes in Europe: need for radical reform

10.1016/s2213-8587(13)70178-5 · 2013 · External reference

The regulation of medical devices and the role of the Medical Devices Agency

10.1046/j.0306-5251.2001.01416.x · 2001 · External reference

Understanding the medical device directive changes

10.2345/0899-8205-43.4.319 · 2009 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

EU and member state medical device regulation

10.1017/s0266462303000217 · 2003 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

How a fake hip showed up failings in the European device regulation

10.1136/bmj.e7090 · 2012 · External reference

Medical device development: from prototype to regulatory approval

10.1161/01.cir.0000134695.65733.64 · 2004 · External reference

Europeans are left to their own devices

10.1136/bmj.d2748 · 2011 · External reference

The EU's system for regulating medical devices: now is the time for radical change

10.1136/bmj.e7126 · 2012 · External reference

The truth behind “made in Europe” labels on medical devices

10.1136/bmj.e7193 · 2012 · External reference

Devices and desires: industry fights toughening of medical device regulation in Europe

10.1136/bmj.f6204 · 2013 · External reference

How does medical device approval regulation perform in the United States and the European Union? A systematic review

10.1371/journal.pmed.1001276 · 2012 · External reference

Postmarketing surveillance of medical devices—filling in the gaps

10.1056/nejmp1114865 · 2012 · External reference

Patient access to medical devices—a comparison of U.S. and European review processes

10.1056/nejmp1204170 · 2012 · External reference

Only 3 in 20 new drugs approved in Germany in 2011 were an improvement, report says

10.1136/bmj.g2657 · 2014 · External reference

Commentary: the risk of over-regulation

10.1136/bmj.d3021 · 2011 · External reference

Medical devices and the approval processes: United States vs. France

10.1001/archinternmed.2010.454 · 2010 · External reference

The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation?

10.1136/neurintsurg-2012-010400 · 2013 · External reference

Review of the processes for FDA oversight of drugs, medical devices and combination products

10.18553/jmcp.2011.17.1.40 · 2011 · External reference

Medical device recalls and the FDA approval process

10.1001/archinternmed.2011.30 · 2011 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

The 501(k) ancestry of a metal-on-metal hip implant

10.1056/nejmp1211581 · 2013 · External reference

Unresolved reference

External reference

Unresolved reference

2012 · External reference

Unresolved reference

2009 · External reference

Medical devices–balancing regulation and innovation

10.1056/nejmp1109094 · 2011 · External reference

Unresolved reference

External reference

The epidemiology of drug recalls in the United States

10.1001/archinternmed.2012.2013 · 2012 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Trial watch: phase II and submission failures 2007-2010

10.1038/nrd3375 · 2011 · External reference

Can the pharmaceutical industry reduce attrition rates?

10.1038/nrd1470 · 2004 · External reference

Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma

10.1038/nrd2664 · 2008 · External reference

Paying for drug approval—who's using whom?

10.1056/nejmp078041 · 2007 · External reference

Approvals of drugs with uncertain benefit-risk profiles in Europe

10.1016/j.ejim.2015.08.008 · 2015 · External reference

Post marketing surveillance and vigilance for medical devices: the European approach

10.2165/00002018-200124120-00001 · 2001 · External reference

The Poly Implant Prosthèse breast prosthesis scandal: embodied risk and social suffering

10.1016/j.socscimed.2015.10.068 · 2014 · External reference

The saga of Poly Implant Prosthèse breast implants

10.1136/bmj.e306 · 2012 · External reference

Medical device regulation: time to improve performance

10.1371/journal.pmed.1001277 · 2012 · External reference

In search of the shocking truth

10.1016/j.hrthm.2012.05.005 · 2012 · External reference

Class I recall of defibrillator leads: a comparison of the Sprint Fidelis and Riata families

10.1016/j.hrthm.2012.04.003 · 2012 · External reference

Deaths caused by failure of Riata and Riata ST implantable cardioverter-defibrillator leads

10.1016/j.hrthm.2012.03.048 · 2012 · External reference

Here we go again—another failure of postmarketing device surveillance

10.1056/nejmp1114695 · 2012 · External reference

Unresolved reference

External reference

Medical-device recalls in the UK and the device regulation process: retrospective review of safety notices and recalls

10.1136/bmjopen-2011-000155 · 2011 · External reference

Unresolved reference

External reference

Assessment of cardiovascular and noncardiovascular medical device recalls

10.1016/j.amjcard.2014.03.024 · 2014 · External reference

The US Food and Drug Administration-European Medicines Agency collaboration in pharmacovigilance: common objectives and common challenges

10.1007/s40264-014-0259-3 · 2015 · External reference

Unresolved reference

External reference